Anti‐EGFR therapy vs placebo or usual care
Neutropenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in neutropenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
- Anti‐epidermal growth factor receptor therapy for glioblastoma in adults 2020 · Cochrane Headline outcomes onlyOR 1.29 [0.82, 2.03]4 studies · 1146 participantsLow